✉ Email this page to a colleague
« Back to Dashboard
Ozobax is a drug marketed by Metacel Pharms Llc and is included in one NDA. There is one patent protecting this drug and one Paragraph IV challenge.
The generic ingredient in OZOBAX is baclofen. There are twenty-one drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the baclofen profile page.
A generic version of OZOBAX was approved as baclofen by IVAX SUB TEVA PHARMS on July 21st, 1988.
Summary for OZOBAX
Pharmacology for OZOBAX
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Metacel Pharms Llc||OZOBAX||baclofen||SOLUTION;ORAL||208193-001||Sep 18, 2019||RX||Yes||Yes||⤷ Try a Trial||⤷ Try a Trial||⤷ Try a Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|